Cargando…
Mild Cognitive Impairment and Neurofeedback: A Randomized Controlled Trial
Background and Objectives: Mild cognitive impairment (MCI) is often a precursor of dementia, and in particular of Alzheimer's Disease (AD) which is the most common cause of dementia. Individuals with amnestic MCI are several-fold more likely to develop AD than the general population. Therefore,...
Autores principales: | Lavy, Yotam, Dwolatzky, Tzvi, Kaplan, Zeev, Guez, Jonathan, Todder, Doron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236892/ https://www.ncbi.nlm.nih.gov/pubmed/34194315 http://dx.doi.org/10.3389/fnagi.2021.657646 |
Ejemplares similares
-
Methylphenidate for Mild Cognitive Impairment: An Exploratory 3-Day, Randomized, Double-Blind, Placebo-Controlled Trial
por: Press, Yan, et al.
Publicado: (2021) -
Validity of a novel computerized cognitive battery for mild cognitive impairment
por: Dwolatzky, Tzvi, et al.
Publicado: (2003) -
Validation of the Russian Version of the MoCA Test as a Cognitive Screening Instrument in Cognitively Asymptomatic Older Individuals and Those With Mild Cognitive Impairment
por: Freud, Tamar, et al.
Publicado: (2020) -
Neurofeedback and the Aging Brain: A Systematic Review of Training Protocols for Dementia and Mild Cognitive Impairment
por: Trambaiolli, Lucas R., et al.
Publicado: (2021) -
Cognitive training based on functional near-infrared spectroscopy neurofeedback for the elderly with mild cognitive impairment: a preliminary study
por: Lee, Ilju, et al.
Publicado: (2023)